Table 2.
Nanoparticle pharmacokinetic properties.
| Particle | Distribution Half-life (t1/2,dist)51 | Kel,dist [min−1] | Elimination Half-life (t1/2,elim)51 | Kel,elim [min−1] | Area under concentration-time curve (AUC) |
|---|---|---|---|---|---|
| Cj-1 | 4.74 ± 1.58 | 0.16 ± 0.055 | 29.69 ± 2.53 | 0.024 ± 0.002 | 152 ± 59 [min mg mL−1] |
| PLGA | 3.12 ± 1.33 | 0.25 ± 0.068 | 44.02 ± 14.23 | 0.017 ± 0.005 | 329 ± 130 [min mg mL−1] |
| Pro-NP | 3.64 ± 1.79 | 0.23 ± 0.11 | 27.74 ± 10.19 | 0.029 ± 0.012 | 6116 ± 3200 [min mg mL−1] |
| Gd-DTPA | 4.01 ± 2.47 | 0.23 ± 0.11 | 15.70 ± 8.50 | 0.056 ± 0.023 | 6.6 ± 3.8 [min mM] |